#ITI#Protection afforded by a recombinant Turkey herpesvirus-H5 vaccine against the 2014 european highly pathogenic H5N8 avian influenza strain#FTI#
#IRE#A highly pathogenic avian influenza (HPAI) H5N8 (clade 2.3.4.4) virus, circulating in Asia (South Korea, Japan, and southern China) since the beginning of 2014, reached the European continent in November 2014. Germany, the Netherlands, The United Kingdom, Italy, and Hungary confirmed H5N8 infection of poultry farms of different species and of several wild bird species. Unlike the Asian highly pathogenic (HP) H5N1, this HP H5N8 also went transatlantic and reached the American West Coast by the end of 2014, affecting wild birds as well as backyard and commercial poultry. This strain induces high mortality and morbidity in Galliformes, whereas wild birds seem only moderately affected. A recombinant Turkey herpesvirus (rHVT) vector vaccine expressing the H5 gene of a clade 2.2 H5N1 strain (rHVT-H5) previously demonstrated a highly efficient clinical protection and reduced viral excretion against challenge with Asian HP H5N1 strains of various clades (2.2, 2.2.1, 2.2.1.1, 2.1.3, 2.1.3.2, and 2.3.2.1) and was made commercially available in various countries where the disease is endemic. To evaluate the protective efficacy of the rHVT-H5 vaccine against the first German H5N8 Turkey isolate (H5N8 GE), a challenge experiment was set up in specificpathogen- free (SPF) chickens, and the clinical and excretional protection was evaluated. SPF chickens were vaccinated subcutaneously at 1 day old and challenged oculonasally at 4 wk of age with two viral dosages, 105 and 106 50% egg infective doses. Morbidity and mortality were monitored daily in unvaccinated and vaccinated groups, whereas viral shedding by oropharyngeal and cloacal routes was evaluated at 2, 5, 9, and 14 days postinoculation (dpi). Serologic monitoring after vaccination and challenge was also carried out. Despite its high antigenic divergence of the challenge H5N8 strain, a single rHVT-H5 vaccine administration at 1 day old resulted in a full clinical protection against challenge and a significant reduction of viral shedding in the vaccinated birds.#FRE#
#IPC#Highly pathogenic avian influenza h5n8; Protective efficacy; Recombinant Turkey herpesvirus-h5 vector vaccine#FPC#
#IRF#Abdelwhab E.M., Grund C., Aly M.M., Beer M., Harder T.C., Hafez H.M., Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against egyptian highly pathogenic avian influenza h5n1, Vet. Microbiol, 155, pp. 13-20, (2012); 
Alexander D.J., A review of avian influenza in different bird species, Vet. Microbiol, 74, pp. 3-13, (2000); 
Bonfante F., Gardin Y., Terregino C., Berton V., Giasuddin M., Das B.C., Yamage M., Palya V., Capua I., Efficacy of a single dose RHVT-H5 avian influenza vector vaccine against a clade 2.3.2.1 of h5n1 highly pathogenic virus, Proceedings, 18th World Veterinary Poultry Association WVPA Congress, (2013); 
Burke D.F., Smith D.J., A recommended numbering scheme for influenza a ha subtypes, Plos One, 9, (2014); 
Cattoli G., Milani A., Temperton N., Zecchin B., Buratin A., Molesti A., Aly M.M., Arafa A., Capua I., Sntigenic drift in H5N1 avian influenza virus in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to those for human influenza, virus, J. Virol, 85, pp. 8718-8724, (2011); 
De Vriese J., Gardin Y., Palya V., Dorsey K.M., Lambrecht B., Borm S.V., Van Den Berg T., Efficacy of a RHVT-AI vector vaccine in broilers, with passive immunity against hvt and aiv, against challenge with H5N1 HPAIV, 16th WVPA Congress, (2009); 
Gu M., Zhao G., Zhao K., Zhong L., Huang J., Wan H., Wang X., Liu W., Liu H., Peng D., Liu X., Novel variants of clade 2.3.4 highly pathogenic avian influenza a(H5N1) viruses, China, Emerg. Infect, Dis, 19, pp. 2021-2024, (2013); 
Jeong J., Kang H.M., Lee E.K., Song B.M., Kwon Y.K., Kim H.R., Choi K.S., Kim J.Y., Lee H.J., Moon O.K., Jeong W., Choi J., Baek J.H., Joo Y.S., Park Y.H., Lee H.S., Lee Y.J., Highly pathogenic avian influenza virus (H5N8) in domestic poultry and its relationship with migratory birds in South Korea during 2014, Vet. Microbiol, 173, pp. 249-257, (2014); 
Jhung M.A., Nelson D.I., Outbreaks of avian influenza a (H5N2), (H5N8), and (H5N1) among birds - United States, December 2014-January 2015, Morb. Mortal. Wkly. Rep, 64, (2015); 
Kang H.M., Lee E.K., Song B.M., Jeong J., Choi J.G., Moon O.K., Yoon H., Cho Y., Kang Y.M., Lee H.S., Lee Y.J., Novel reassortant influenza a (H5N8) viruses among inoculated domestic and wild ducks, South Korea, 2014, Emerg. Infect. Dis, 21, pp. 298-304, (2015); 
Kapczynski D.R., Esaki M., Dorsey K.M., Jiang H., Jackwood M., Moraes M., Gardin Y., Vaccine protection of chickens against antigenically diverse h5 highly pathogenic avian influenza isolates with a live hvt vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus, Vaccine, 33, pp. 1197-1205, (2015); 
Kaverin N.V., Rudneva I.A., Govorkova E.A., Timofeeva T.A., Shilov A.A., Kochergin-Nikitsky K.S., Krylov P.S., Webster R.G., Epitope mapping of the hemagglutinin molecule of a highly pathogenic h5n1 influenza virus by using monoclonal antibodies, J. Virol, 81, pp. 12911-12917, (2007); 
Kaverin N.V., Rudneva I.A., Ilyushina N.A., Varich N.L., Lipatov A.S., Smirnov Y.A., Govorkova E.A., Gitelman A.K., Lvov D.K., Webster R.G., Structure of antigenic sites on the haemagglutinin molecule of h5 avian influenza virus and phenotypic variation of escape mutants, J. Gen. Virol, 83, pp. 2497-2505, (2002); 
Kilany W., Dauphin G., Selim A., Tripodi A., Samy M., Sobhy H., VonDobschuetz S., Safwat M., Saad M., Erfan A., Hassan M., Lubroth J., Jobre Y., Protection conferred by recombinant Turkey herpesvirus avian influenza (rhvt-h5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt, Avian Pathol, 43, pp. 514-523, (2014); 
Kilany W.H., Abdelwhab E.M., Arafa A.S., Selim A., Safwat M., Nawar A.A., Erfan A.M., Hassan M.K., Aly M.M., Hafez H.M., Protective efficacy of h5 inactivated vaccines in meat Turkey poults after challenge with egyptian variant highly pathogenic avian influenza h5n1 virus, Vet. Microbiol, 150, pp. 28-34, (2011); 
Kilany W.H., Khalifa M.K., Safwat M., Mohammed S., Selim A., VonDobschuetz S., Dauphin G., Lubroth J., Jobre Y., Comparison of the effectiveness of rHVT-H5, inactivated h5 and rhvt-h5 with inactivated h5 prime/boost vaccination regimes in commercial broiler chickens carrying mdas against hpai h5n1 clade 2.2.1 virus challenge, Avian Pathol, 22, pp. 333-341, (2015); 
Kim Y., Pascua P.N., Kwon H.I., Lim G.J., Kim E.H., Yoon S.W., Park S.J., Kim S.M., Choi E.J., Si Y.J., Lee O.J., Shim W.S., Kim S.W., Mo I.P., Bae Y., Lim Y.T., Sung M.H., Kim C.J., Webby R.J., Webster R., Choi Y.K., Pathobiological features of a novel, highly pathogenic avian influenza a(h5n8) virus, Emerg. Microbes Infect, 3, (2014); 
Lambrecht B., Steensels M., Borm S.V., Meulemans G., Berg T.V.D., Development of a m2e-specific elisa for diva testing, Avian Dis, 51, pp. 221-226, (2007); 
Lee Y.J., Kang H.M., Lee E.K., Song B.M., Jeong J., Kwon Y.K., Kim H.R., Lee K.J., Hong M.S., Jang I., Choi K.S., Kim J.Y., Lee H.J., Kang M.S., Jeong O.M., Baek J.H., Joo Y.S., Park Y.H., Lee H.S., Novel reassortant influenza a(H5N8) viruses, South Korea, 2014, Emerg. Infect. Dis, 20, pp. 1087-1089, (2014); 
Li J., Wang Y., Liang Y., Ni B., Wan Y., Liao Z., Chan K.H., Yuen K.Y., Fu X., Shang X., Wang S., Yi D., Guo B., Di B., Wang M., Che X., Wu Y., Fine antigenic variation within h5n1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface, display, Eur. J. Immunol, 39, pp. 3498-3510, (2009); 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, (2015); 
Park J.K., Lee D.H., Youn H.N., Kim M.S., Lee Y.N., Yuk S.S., Lim T.H., Jang J.H., Kwon J.H., Kim B.Y., Kang S.M., Seong B.L., Lee J.B., Park S.Y., Choi I.S., Song C.S., Protective efficacy of crude viruslike particle vaccine against hpai h5n1 in chickens and its application on diva strategy, Influenza other Respir. Viruses, 7, pp. 340-348, (2013); 
Pedersen J.C., Hemagglutination-inhibition test for avian influenza virus subtype identification and the detection and quantitation of serum antibodies to the avian influenza virus, Methods Mol. Biol, 436, pp. 53-66, (2008); 
Rauw F., Anbari S., Van Den Berg T., Lambrecht B., Measurement of systemic and local respiratory cell-mediated immunity after influenza infection in chickens, Vet. Immunol, Immunopathol, 143, pp. 27-37, (2011); 
Rauw F., Gardin Y., Palya V., Borm S.V., Gonze M., Lemaire S., Van Den Berg T., Lambrecht B., Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old spf and conventional layer chicks with two different live newcastle disease vaccines, Vaccine, 27, pp. 3631-3642, (2009); 
Rauw F., Palya V., Gardin Y., Tatar-Kis T., Dorsey K.M., Lambrecht B., Van Den Berg T., Efficacy of rhvt-Ai vector vaccine in broilers with passive immunity against challenge with two antigenically divergent egyptian clade 2.2.1 hpai h5n1 strains, Avian Dis, 56, pp. 913-922, (2012); 
Rauw F., Palya V., Borm S.V., Welby S., Tatar-Kis T., Gardin Y., Dorsey K.M., Aly M.M., Hassan M.K., Soliman M.A., Lambrecht B., Van Den Berg T., Further evidence of antigenic drift and protective efficacy afforded by a recombinant hvt-h5 vaccine against challenge with two antigenically divergent egyptian clade 2.2.1 hpai h5n1 strains, Vaccine, 29, pp. 2590-2600, (2011); 
Seo S.H., Webster R.G., Cross-reactive, cell-mediated immunity and protection of chickens from lethal h5n1 influenza virus infection in Hong Kong poultry markets, J. Virol, 75, pp. 2516-2525, (2001); 
Soejoedono R.D., Murtini S., Palya V., Felfoldi B., Mato T., Gardin Y., Efficacy of a recombinant HVT-H5 vaccine against challenge with two genetically divergent Indonesian HPAI H5N1 strains, Avian Dis, 56, pp. 923-927, (2012); 
Spackman E., Senne D.A., Myers T.J., Bulaga L.L., Garber L.P., Perdue M.L., Lohman K., Daum L.T., Suarez D.L., Development of a real-time reverse transcriptase PCR assay for type a influenza virus and the avian h5 and h7 hemagglutinin subtypes, J. Clin. Microbiol, 40, pp. 3256-3260, (2002); 
Spickler A.R., Trampel D.W., Roth J.A., The onset of virus shedding and clinical signs in chickens infected with high-pathogenicity and low-pathogenicity avian influenza viruses, Avian Pathol, 37, pp. 555-577, (2008); 
Suzuki K., Okada H., Itoh T., Tada T., Tsukamoto K., Phenotypes influencing the transmissibility of highly pathogenic avian influenza viruses in chickens, J. Gen. Virol, 91, pp. 2302-2306, (2010); 
Swayne D.E., Impact of vaccines and vaccination on global control of avian influenza, Avian Dis, 56, pp. 818-828, (2012); 
Swayne D.E., Kapczynski D., Strategies and challenges for eliciting immunity against avian influenza virus in birds, Immunol. Rev, 225, pp. 314-331, (2008); 
Swayne D.E., Pantin-Jackwood M., Pathogenicity of avian influenza viruses in poultry, Dev. Biol. (Basel), 124, pp. 61-67, (2006); 
Swayne D.E., Spackman E., Pantin-Jackwood M., Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-Agricultural interface, Ecohealth, 11, pp. 94-108, (2014); 
Terregino C., Toffan A., Cilloni F., Monne I., Bertoli E., Castellanos L., Amarin N., Mancin M., Capua I., Evaluation of the protection induced by avian influenza vaccines containing a 1994 mexican h5n2 lpai seed strain against a 2008 egyptian h5n1 hpai virus belonging to clade 2.2.1 by means of serological and in vivo tests, Avian Pathol, 39, pp. 215-222, (2010); 
Continued evolution of highly pathogenic avian influenza a (H5N1): Updated nomenclature, Influenza other Respir, 6, pp. 1-5, (2012); 
Wu H., Peng X., Xu L., Jin C., Cheng L., Lu X., Xie T., Yao H., Wu N., Characterization of a novel highly pathogenic h5n2 avian influenza virus isolated from a duck in eastern China, Arch. Virol, 159, pp. 3377-3383, (2014); 
Wu H., Peng X., Xu L., Jin C., Cheng L., Lu X., Xie T., Yao H., Wu N., Novel reassortant influenza a(H5N8) viruses in domestic ducks, eastern China, Emerg. Infect. Dis, 20, pp. 1315-1318, (2014); 
Zhao G., Gu X., Lu X., Pan J., Duan Z., Zhao K., Gu M., Liu Q., He L., Chen J., Ge S., Wang Y., Chen S., Wang X., Peng D., Wan H., Liu X., Novel reassortant highly pathogenic h5n2 avian influenza viruses in poultry in China, Plos One, 7, (2012); 
Zhao K., Gu M., Zhong L., Duan Z., Zhang Y., Zhu Y., Zhao G., Zhao M., Chen Z., Hu S., Liu W., Liu X., Peng D., Characterization of three h5n5 and one h5n8 highly pathogenic avian influenza viruses in China, Vet. Microbiol, 163, pp. 351-357, (2013); 
Zhao Q., Li Q., Zhong L., Gu M., Zhu J., Zhao G., Chen C., Wang X., Liu X., Complete genomic sequence of a novel reassortant H4N2 avian influenza virus isolated from domestic ducks in jiangsu, China. Genome Announc, 1, (2013); 
Zhao S., Suo L., Jin M., Genetic characterization of a novel recombinant H5N2 avian influenza virus isolated from chickens in tibet, J. Virol, 86, pp. 13836-13837, (2012)#FRF#
